Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.
about
The genetics of attention deficit/hyperactivity disorder in adults, a reviewAdvances in understanding and treating ADHDBiomarkers in the diagnosis of ADHD--promising directionsGenome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorderComparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone AcetonideIdentification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorderGenome-wide association studies in pharmacogenomics: successes and lessons.Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample.Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Monoamine transporters: vulnerable and vital doorkeepers.Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory studyGenetic factors modulating the response to stimulant drugs in humans.Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.mGluR7 genetics and alcohol: intersection yields clues for addiction.Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate ReceptorsPharmacogenomics in clinical practice and drug development.A current update on ADHD pharmacogenomics.Effects of exogenous agents on brain development: stress, abuse and therapeutic compounds.Neurobiology of attention deficit/hyperactivity disorder.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.Attention-deficit/hyperactivity disorder genomics: update for clinicians.Genetics of attention-deficit/hyperactivity disorder: current findings and future directions.Background, clinical features and treatment of attention deficit hyperactivity disorder in children.ADHD pharmacogenetics across the life cycle: New findings and perspectives.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder.Pharmacogenomic genome-wide association studies: lessons learned thus far.Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Association of genetic risk severity with ADHD clinical characteristics.Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines.Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder.Sex Differences in Psychiatric Disease: A Focus on the Glutamate System.
P2860
Q22251103-3EBBBC01-A6BF-4DB8-89C3-2110A30911EBQ24601949-9C9DA115-2251-4FAE-8F82-B823441B3AC2Q28249420-52D55956-27DB-44E2-853D-9996F588FDEAQ28254567-F7E31300-EBE6-423F-82B9-1F522B2360F5Q28383760-FE851EC7-025D-4C05-A308-BFF397CBAB3FQ30402875-F19853E2-824F-4CB4-9286-5B12A4DA2B77Q33870580-53904723-572E-4C2A-9350-9DE8166A3BC1Q34221423-911C94D3-E37E-4ED1-8B16-693CE54D160DQ34415006-BE7DE427-ECB6-4D4D-AF8A-3EACBB78446EQ34490272-8C2DF1C2-4430-42C0-A2C0-5391448D5E72Q34538304-BE912669-97F6-4544-BB31-6C8DE2A2F4BEQ35575795-AAB079C5-3DA4-4A67-BE64-D660BE28A018Q35877150-C81BC7A9-AA42-489B-B973-F17AFD8E54E3Q35970045-97DD84B0-408D-4DED-ADEA-2C4929C936D9Q36071808-F3D5C593-9AEE-4707-8CE7-6FEA3FE47F8DQ36191809-75327C17-8C81-4050-9CDA-B9DCF7936471Q36197596-1E6E2639-20D3-43EC-ABE5-B9B41D922B59Q37183072-122059D3-606A-4A38-903D-A5A83A896A93Q37284234-5D71A43A-4E3D-460D-82AD-403B473FC6CCQ37710514-89D99431-4DE1-47BB-8CD8-08D35D32838AQ37765634-845A08BC-B2D5-400B-8ED1-4550A28C28BEQ37834929-1EABF245-FF0D-4879-910C-186BBC60246FQ37960505-C07DB3EF-466D-43AC-B775-050242A0EFA5Q38030489-11A8E512-8CD8-445C-B688-7840282E949EQ38094814-3B7546F8-A4F8-49CD-8A81-541931ECFEA5Q38122410-034F31A5-1FFD-45F7-A8E3-F25B352A7E3DQ38209972-5590FE1A-2AD6-4627-85DB-BB9CE21435E2Q38243174-0A66DEF6-FCEF-4CA0-9FA1-2357C051EFCDQ38251282-1D7BA2C6-D189-4728-BA04-04FBEF591D9CQ38410122-7D33EE8E-7D74-44DD-A77C-27CA822BB8B2Q38447329-C521FA76-5683-4B72-A49C-FB6D292EE9DFQ41874051-061498C0-33E7-4C84-9C26-24AB757F4A95Q44596771-188DA329-EE41-4A76-9D93-F74BEBC3BC8FQ46040109-92929816-A892-4B72-B703-DEED8EE43A42Q47550540-A5379BF5-1887-44D4-A07C-0F08DBA6C322Q47967896-220DBD49-9923-421E-9CD3-DB4A7EE0C4F6Q50066117-7883940A-C8B1-4E64-BB1E-37AD48319A67Q50266015-2BA44A96-445A-47CC-A4E2-388B24EF6023Q54441345-FC3246BD-7691-4B28-9604-8DDF6F8FF7B3Q55177239-0A8626A3-0147-4FFF-AA48-01045EA76654
P2860
Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Genome-wide association study ...... eficit/hyperactivity disorder.
@en
Genome-wide association study ...... eficit/hyperactivity disorder.
@nl
type
label
Genome-wide association study ...... eficit/hyperactivity disorder.
@en
Genome-wide association study ...... eficit/hyperactivity disorder.
@nl
prefLabel
Genome-wide association study ...... eficit/hyperactivity disorder.
@en
Genome-wide association study ...... eficit/hyperactivity disorder.
@nl
P2093
P356
P1476
Genome-wide association study ...... eficit/hyperactivity disorder.
@en
P2093
Benjamin Neale
Frank A Middleton
James J McGough
P304
P356
10.1002/AJMG.B.30865
P577
2008-12-01T00:00:00Z